Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Antiviral activity against Human poliovirus 1 Sabin | ChEMBL. | 18054491 |
Activity (functional) | 0 | Antiviral activity against vesicular stomatitis virus | ChEMBL. | 18054491 |
Activity (functional) | 0 | Antiviral activity against vaccinia virus | ChEMBL. | 18054491 |
Activity (functional) | 0 | Antiviral activity against Reovirus | ChEMBL. | 18054491 |
Activity (functional) | 0 | Antiviral activity against HIV1 | ChEMBL. | 18054491 |
CC50 (ADMET) | = 28 uM | Cytotoxicity against human MT4 cells after 96 hrs by MTT method | ChEMBL. | 18054491 |
CC50 (ADMET) | = 28 uM | Cytotoxicity against human MT4 cells after 96 hrs by MTT method | ChEMBL. | 18054491 |
EC50 (functional) | > 18 uM | Antiviral activity against BVDV NADL in MDBK cells assessed as protection from virus-induced cytopathogenicity by MTT method | ChEMBL. | 18054491 |
EC50 (functional) | > 53 uM | Antiviral activity against YFV in BHK cells assessed as protection from virus-induced cytopathogenicity by MTT method | ChEMBL. | 18054491 |
EC50 (functional) | > 100 uM | Antiviral activity against RSV A2 in VERO76 cells assessed as reduction of plaque number by MTT method | ChEMBL. | 18054491 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.